课题基金 / 基金详情

An 'unconventional' approach to the COVID 19 pandemic: the role of T cells in virus recognition

An 'unconventional' approach to the COVID 19 pandemic: the role of T cells in virus recognition
应对 COVID 19 大流行的“非常规”方法:T 细胞在病毒识别中的作用
批准号:
2734802
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
TBCThis dynamic project will bring together two established groups to investigate the potentially crucial role of non-conventional immune responses to SARS-CoV-2. The response to the COVID19 pandemic has been rapid and has led to the successful development of vaccines that target the viral Spike protein. Whilst this has had a substantial impact on COVID19, it is has also highlighted that the specificity of Spike-based vaccines might also be their Achilles heel. Indeed, sustained world-wide virus transmission has resulted in the emergence of variants that can render the vaccine programmes ineffective due to mismatch between the circulating Spike sequences and those used for the vaccines. It is therefore crucial to investigate strategies that are independent of virus sequences. This exciting project will investigate the potential of the innate immune response against viral diseases and how unconventional T cells (i.e. T cell) respond rapidly to infected cells by recognising 'danger signals' expressed by these cells. In particular, the project asks three related but free-standing questions: 1. What are the signals on the infected cells that trigger this fast "detection and kill" approach by unconventional T cells? 2. What are the molecular mechanisms that unravel within unconventional T cells to generate that "detection and kill" approach? 3. Are danger signals and responses present in tissues from SARS-CoV-2 infected non-human primates? The project will require a wide range of techniques including cell culture (cell lines; primary cells), flow-cytometry, western blotting; work with replication competent SARS-CoV-2 (BSL3 containment laboratory at SGUL). Immunohistochemistry and in situ hybridisation of SARS-CoV-2 non-human primate tissues will be undertaken at the Comparative Pathology team at UK Health Security Agency (Porton Down), where the successful applicant will be expected to spend 3 months (placement). This project suits a self-motivated person with a strong will to learn and deliver. You will have a strong interest in immunology and its impact in global health, coupled with a pro-active attitude to problem-solving.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
量化 domain 的拓扑性质
  • 批准号:
    11771310
  • 项目类别:
    面上项目
  • 资助金额:
    48.0万元
  • 批准年份:
    2017
  • 负责人:
    赖洪亮
  • 依托单位:
基于Riemann-Hilbert方法的相关问题研究
  • 批准号:
    11026205
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    3.0万元
  • 批准年份:
    2010
  • 负责人:
    周建荣
  • 依托单位:
EnSite array指导下对Stepwise approach无效的慢性房颤机制及消融径线设计的实验研究
  • 批准号:
    81070152
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    唐恺
  • 依托单位:
MBR中溶解性微生物产物膜污染界面微距作用机制定量解析
  • 批准号:
    50908133
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2009
  • 负责人:
    梁爽
  • 依托单位: